Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 3/2017

01-03-2017 | Maternal-Fetal Medicine

Pregnancy outcomes in HIV-positive women: a retrospective cohort study

Authors: Kholoud Arab, Andrea R. Spence, Nicholas Czuzoj-Shulman, Haim A. Abenhaim

Published in: Archives of Gynecology and Obstetrics | Issue 3/2017

Login to get access

Abstract

Purpose

In the United States, an estimated 8500 HIV (human immunodeficiency virus) positive women gave birth in 2014. This rate appears to be increasing annually. Our objective is to examine obstetrical outcomes of pregnancy among HIV-positive women.

Methods

A population-based cohort study was conducted using the Nationwide Inpatient Sample database (2003–2011) from the United States. Pregnant HIV-positive women were identified and compared to pregnant women without HIV. Multivariate logistic regression was used to estimate the adjusted effect of HIV status on obstetrical and neonatal outcomes.

Results

Among 7,772,999 births over the study period, 1997 were in HIV-positive women (an incidence of 25.7/100,000 births). HIV-infected patients had greater frequency of pre-existing diabetes and chronic hypertension, and use of cigarettes, drugs, and alcohol during pregnancy (p < 0.001). Upon adjustment for baseline characteristics, HIV-infected women had greater likelihood of antenatal complications: preterm premature rupture of membranes (OR 1.35, 95% CI 1.14–1.60) and urinary tract infections (OR 3.02, 95% CI 2.40–3.81). Delivery and postpartum complications were also increased among HIV-infected women: cesarean delivery (OR 3.06, 95% CI 2.79–3.36), postpartum sepsis (OR 8.05, 95% CI 5.44–11.90), venous thromboembolism (OR 2.21, 95% CI 1.46–3.33), blood transfusions (OR 3.67, 95% CI 3.01–4.49), postpartum infection (OR 3.00, 95% CI 2.37–3.80), and maternal mortality (OR 21.52, 95% CI 12.96–35.72). Neonates born to these mothers were at higher risk of prematurity and intrauterine growth restriction.

Conclusion

Pregnancy in HIV-infected women is associated with adverse maternal and newborn complications. Pregnant HIV-positive women should be followed in high-risk healthcare centers.
Literature
5.
go back to reference Reitter A, Stucker AU, Linde R, Konigs C, Knecht G, Herrmann E et al (2014) Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort. HIV Med 15:525–536CrossRefPubMed Reitter A, Stucker AU, Linde R, Konigs C, Knecht G, Herrmann E et al (2014) Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort. HIV Med 15:525–536CrossRefPubMed
6.
go back to reference Yudin MH, Caprara D, MacGillivray SJ, Urquia M, Shah RR (2016) A ten-year review of antenatal complications and pregnancy outcomes among HIV-positive pregnant women. J Obstet Gynaecol Can 38:35–40CrossRefPubMed Yudin MH, Caprara D, MacGillivray SJ, Urquia M, Shah RR (2016) A ten-year review of antenatal complications and pregnancy outcomes among HIV-positive pregnant women. J Obstet Gynaecol Can 38:35–40CrossRefPubMed
7.
go back to reference Marti C, Pena JM, Bates I, Madero R, de Jose I, Pallardo LF et al (2007) Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003. Acta Obstet Gynecol Scand 86:409–415CrossRefPubMed Marti C, Pena JM, Bates I, Madero R, de Jose I, Pallardo LF et al (2007) Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003. Acta Obstet Gynecol Scand 86:409–415CrossRefPubMed
8.
go back to reference Brocklehurst P, French R (1998) The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 105:836–848CrossRefPubMed Brocklehurst P, French R (1998) The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 105:836–848CrossRefPubMed
9.
go back to reference Ewing AC, Datwani HM, Flowers LM, Ellington SR, Jamieson DJ, Kourtis AP (2016) Trends in hospitalizations of pregnant HIV-infected women in the United States: 2004 through 2011. Am J Obstet Gynecol 215:499e1–499e8CrossRef Ewing AC, Datwani HM, Flowers LM, Ellington SR, Jamieson DJ, Kourtis AP (2016) Trends in hospitalizations of pregnant HIV-infected women in the United States: 2004 through 2011. Am J Obstet Gynecol 215:499e1–499e8CrossRef
10.
go back to reference Kourtis AP, Bansil P, McPheeters M, Meikle SF, Posner SF, Jamieson DJ (2006) Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994–2003. AIDS (London, England) 20:1823–31 Kourtis AP, Bansil P, McPheeters M, Meikle SF, Posner SF, Jamieson DJ (2006) Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994–2003. AIDS (London, England) 20:1823–31
11.
go back to reference Gonzalez-Tome MI, Ramos Amador JT, Guillen S, Solis I, Fernandez-Ibieta M, Munoz E et al (2008) Gestational diabetes mellitus in a cohort of HIV-1 infected women. HIV Med 9:868–874CrossRefPubMed Gonzalez-Tome MI, Ramos Amador JT, Guillen S, Solis I, Fernandez-Ibieta M, Munoz E et al (2008) Gestational diabetes mellitus in a cohort of HIV-1 infected women. HIV Med 9:868–874CrossRefPubMed
12.
go back to reference Lopez M, Figueras F, Hernandez S, Lonca M, Garcia R, Palacio M, et al (2012) Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART. AIDS (London, England) 26:37–43 Lopez M, Figueras F, Hernandez S, Lonca M, Garcia R, Palacio M, et al (2012) Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART. AIDS (London, England) 26:37–43
13.
go back to reference Kourtis AP, Schmid CH, Jamieson DJ, Lau J (2007) Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS (London, England) 21:607–615 Kourtis AP, Schmid CH, Jamieson DJ, Lau J (2007) Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS (London, England) 21:607–615
14.
go back to reference Rasmussen LD, Dybdal M, Gerstoft J, Kronborg G, Larsen CS, Pedersen C et al (2011) HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study. HIV Med 12:202–210CrossRefPubMed Rasmussen LD, Dybdal M, Gerstoft J, Kronborg G, Larsen CS, Pedersen C et al (2011) HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study. HIV Med 12:202–210CrossRefPubMed
15.
go back to reference Jansen JM, Lijfering WM, Sprenger HG, van der Meer J, van Pampus MG (2008) Venous thromboembolism in HIV-positive women during puerperium: a case series. Blood Coagul Fibrinolysis 19:95–97CrossRefPubMed Jansen JM, Lijfering WM, Sprenger HG, van der Meer J, van Pampus MG (2008) Venous thromboembolism in HIV-positive women during puerperium: a case series. Blood Coagul Fibrinolysis 19:95–97CrossRefPubMed
16.
go back to reference Weiss AJ, Elixhauser A (2006) Overview of Hospital Stays in the United States, 2012: Statistical Brief #180. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Health Care Policy and Research (US) Weiss AJ, Elixhauser A (2006) Overview of Hospital Stays in the United States, 2012: Statistical Brief #180. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Health Care Policy and Research (US)
17.
go back to reference Berthelsen CL (2000) Evaluation of coding data quality of the HCUP National Inpatient Sample. Top Health Inform Manag 21:10–23 Berthelsen CL (2000) Evaluation of coding data quality of the HCUP National Inpatient Sample. Top Health Inform Manag 21:10–23
19.
go back to reference Reshi P, Lone IM (2010) Human immunodeficiency virus and pregnancy. Arch Gynecol Obstet 281:781–792CrossRefPubMed Reshi P, Lone IM (2010) Human immunodeficiency virus and pregnancy. Arch Gynecol Obstet 281:781–792CrossRefPubMed
20.
go back to reference Gilling-Smith C, Nicopoullos JD, Semprini AE, Frodsham LC (2006) HIV and reproductive care—a review of current practice. BJOG 113:869–878CrossRefPubMed Gilling-Smith C, Nicopoullos JD, Semprini AE, Frodsham LC (2006) HIV and reproductive care—a review of current practice. BJOG 113:869–878CrossRefPubMed
21.
go back to reference Barnhart N, Shannon M, Weber S, Cohan D (2009) Assisted reproduction for couples affected by human immunodeficiency virus in California. Fertil Steril 91:1540–1543CrossRefPubMed Barnhart N, Shannon M, Weber S, Cohan D (2009) Assisted reproduction for couples affected by human immunodeficiency virus in California. Fertil Steril 91:1540–1543CrossRefPubMed
22.
go back to reference Frodsham LC, Boag F, Barton S, Gilling-Smith C (2006) Human immunodeficiency virus infection and fertility care in the United Kingdom: demand and supply. Fertil Steril 85:285–289CrossRefPubMed Frodsham LC, Boag F, Barton S, Gilling-Smith C (2006) Human immunodeficiency virus infection and fertility care in the United Kingdom: demand and supply. Fertil Steril 85:285–289CrossRefPubMed
23.
go back to reference Chen JL, Philips KA, Kanouse DE, Collins RL, Miu A (2001) Fertility desires and intentions of HIV-positive men and women. Fam Plan Perspect 33(144–52):65 Chen JL, Philips KA, Kanouse DE, Collins RL, Miu A (2001) Fertility desires and intentions of HIV-positive men and women. Fam Plan Perspect 33(144–52):65
24.
go back to reference Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, et al (2008) Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS (London, England) 22:289–299 Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, et al (2008) Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS (London, England) 22:289–299
25.
go back to reference European Collaborative S (2005) Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40:458–465CrossRef European Collaborative S (2005) Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40:458–465CrossRef
26.
go back to reference Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P et al (1992) Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 340:1317–1319CrossRefPubMed Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P et al (1992) Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 340:1317–1319CrossRefPubMed
27.
go back to reference Pena JE, Thornton MH, Sauer MV (2003) Assessing the clinical utility of in vitro fertilization with intracytoplasmic sperm injection in human immunodeficiency virus type 1 serodiscordant couples: report of 113 consecutive cycles. Fertil Steril 80:356–362CrossRefPubMed Pena JE, Thornton MH, Sauer MV (2003) Assessing the clinical utility of in vitro fertilization with intracytoplasmic sperm injection in human immunodeficiency virus type 1 serodiscordant couples: report of 113 consecutive cycles. Fertil Steril 80:356–362CrossRefPubMed
28.
go back to reference Gingelmaier A, Wiedenmann K, Sovric M, Mueller M, Kupka MS, Sonnenberg-Schwan U et al (2011) Consultations of HIV-infected women who wish to become pregnant. Arch Gynecol Obstet 283:893–898CrossRefPubMed Gingelmaier A, Wiedenmann K, Sovric M, Mueller M, Kupka MS, Sonnenberg-Schwan U et al (2011) Consultations of HIV-infected women who wish to become pregnant. Arch Gynecol Obstet 283:893–898CrossRefPubMed
29.
go back to reference Kourtis AP, Ellington S, Pazol K, Flowers L, Haddad L, Jamieson DJ (2014) Complications of cesarean deliveries among HIV-infected women in the United States. AIDS (London, England) 28:2609–2618 Kourtis AP, Ellington S, Pazol K, Flowers L, Haddad L, Jamieson DJ (2014) Complications of cesarean deliveries among HIV-infected women in the United States. AIDS (London, England) 28:2609–2618
30.
go back to reference Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla JL, Delfraissy JF et al (1998) Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA 280:55–60CrossRefPubMed Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla JL, Delfraissy JF et al (1998) Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA 280:55–60CrossRefPubMed
31.
go back to reference (1999). The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1–a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med 340:977–987 (1999). The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1–a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med 340:977–987
32.
go back to reference European Mode of Delivery C (1999) Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 353:1035–1039CrossRef European Mode of Delivery C (1999) Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 353:1035–1039CrossRef
33.
go back to reference Committee on Obstetric P (2001) ACOG committee opinion scheduled Cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234, May 2000 (replaces number 219, August 1999). Int J Gynaecol Obstet 73:279–281CrossRef Committee on Obstetric P (2001) ACOG committee opinion scheduled Cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234, May 2000 (replaces number 219, August 1999). Int J Gynaecol Obstet 73:279–281CrossRef
34.
go back to reference Briand N, Jasseron C, Sibiude J, Azria E, Pollet J, Hammou Y et al (2013) Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010. Am J Obstet Gynecol 209:335.e1–335.e12CrossRef Briand N, Jasseron C, Sibiude J, Azria E, Pollet J, Hammou Y et al (2013) Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010. Am J Obstet Gynecol 209:335.e1–335.e12CrossRef
35.
go back to reference Islam S, Oon V, Thomas P (2010) Outcome of pregnancy in HIV-positive women planned for vaginal delivery under effective antiretroviral therapy. J Obstet Gynaecol 30:38–40CrossRefPubMed Islam S, Oon V, Thomas P (2010) Outcome of pregnancy in HIV-positive women planned for vaginal delivery under effective antiretroviral therapy. J Obstet Gynaecol 30:38–40CrossRefPubMed
36.
go back to reference CDC (2006) Achievements in Public Health: Reduction in Perinatal Transmission of HIV Infection—United States, 1985–2005 CDC (2006) Achievements in Public Health: Reduction in Perinatal Transmission of HIV Infection—United States, 1985–2005
37.
go back to reference Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA (2008) Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006. AIDS (London, England) 22:973–981 Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA (2008) Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006. AIDS (London, England) 22:973–981
38.
go back to reference Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE et al (1996) A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 335:468–474CrossRefPubMed Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE et al (1996) A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 335:468–474CrossRefPubMed
39.
go back to reference Park JC, Buono D, Smith DK, Peipert JF, Sobel J, Rompalo A et al (2002) Urinary tract infections in women with or at risk for human immunodeficiency virus infection. Am J Obstet Gynecol 187:581–588CrossRefPubMed Park JC, Buono D, Smith DK, Peipert JF, Sobel J, Rompalo A et al (2002) Urinary tract infections in women with or at risk for human immunodeficiency virus infection. Am J Obstet Gynecol 187:581–588CrossRefPubMed
40.
go back to reference Bansil P, Jamieson DJ, Posner SF, Kourtis AP (2007) Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART). J Women’s Health 16:159–162CrossRef Bansil P, Jamieson DJ, Posner SF, Kourtis AP (2007) Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART). J Women’s Health 16:159–162CrossRef
41.
go back to reference Graham WHJ (2003) Measuring and estimating maternal mortality in the era of HIV/AIDS. Workshop on HIV/AIDS and adult mortality in developing countries. Population Division, New York Graham WHJ (2003) Measuring and estimating maternal mortality in the era of HIV/AIDS. Workshop on HIV/AIDS and adult mortality in developing countries. Population Division, New York
42.
go back to reference Aagaard-Tillery KM, Lin MG, Lupo V, Buchbinder A, Ramsey PS (2006) Preterm premature rupture of membranes in human immunodeficiency virus-infected women: a novel case series. Infect Dis Obstet Gynecol 2006:53234CrossRefPubMedPubMedCentral Aagaard-Tillery KM, Lin MG, Lupo V, Buchbinder A, Ramsey PS (2006) Preterm premature rupture of membranes in human immunodeficiency virus-infected women: a novel case series. Infect Dis Obstet Gynecol 2006:53234CrossRefPubMedPubMedCentral
43.
go back to reference Minkoff H, Burns DN, Landesman S, Youchah J, Goedert JJ, Nugent RP et al (1995) The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 173:585–589CrossRefPubMed Minkoff H, Burns DN, Landesman S, Youchah J, Goedert JJ, Nugent RP et al (1995) The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 173:585–589CrossRefPubMed
44.
go back to reference Xiao PL, Zhou YB, Chen Y, Yang MX, Song XX, Shi Y et al (2015) Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studies. BMC Pregnancy Childbirth 15:246CrossRefPubMedPubMedCentral Xiao PL, Zhou YB, Chen Y, Yang MX, Song XX, Shi Y et al (2015) Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studies. BMC Pregnancy Childbirth 15:246CrossRefPubMedPubMedCentral
45.
go back to reference Kourtis AP, Fowler MG (2011) Antiretroviral use during pregnancy and risk of preterm delivery: more questions than answers. J Infect Dis 204:493–494CrossRefPubMed Kourtis AP, Fowler MG (2011) Antiretroviral use during pregnancy and risk of preterm delivery: more questions than answers. J Infect Dis 204:493–494CrossRefPubMed
46.
go back to reference Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA (2007) Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS (London, England) 21:1019–1026 Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA (2007) Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS (London, England) 21:1019–1026
47.
go back to reference Auerbach E, Aboulafia DM (2012) Venous and arterial thromboembolic complications associated with HIV infection and highly active antiretroviral therapy. Semin Thromb Hemost 38:830–838CrossRefPubMed Auerbach E, Aboulafia DM (2012) Venous and arterial thromboembolic complications associated with HIV infection and highly active antiretroviral therapy. Semin Thromb Hemost 38:830–838CrossRefPubMed
48.
go back to reference Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S et al (2012) Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis 206:1695–1705CrossRefPubMedPubMedCentral Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S et al (2012) Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis 206:1695–1705CrossRefPubMedPubMedCentral
49.
go back to reference Ezechi OC, Gab-Okafor CV, Oladele DA, Kalejaiye OO, Oke BO, Ohwodo HO et al (2013) Pregnancy, obstetric and neonatal outcomes in HIV positive Nigerian women. Afr J Reprod Health 17:160–168PubMed Ezechi OC, Gab-Okafor CV, Oladele DA, Kalejaiye OO, Oke BO, Ohwodo HO et al (2013) Pregnancy, obstetric and neonatal outcomes in HIV positive Nigerian women. Afr J Reprod Health 17:160–168PubMed
50.
go back to reference HIV and AIDS in Canada. Surveillance Report to December 31, 2008. Ottawa: Surveillance and Risk Assessment Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, 2009 HIV and AIDS in Canada. Surveillance Report to December 31, 2008. Ottawa: Surveillance and Risk Assessment Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, 2009
Metadata
Title
Pregnancy outcomes in HIV-positive women: a retrospective cohort study
Authors
Kholoud Arab
Andrea R. Spence
Nicholas Czuzoj-Shulman
Haim A. Abenhaim
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 3/2017
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-016-4271-y

Other articles of this Issue 3/2017

Archives of Gynecology and Obstetrics 3/2017 Go to the issue